SCHEMBL8896860

SCHEMBL8896860

CCCCC(CCCO)O[SiH](C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
SMN1; SMN2 Q16637 1/20 0.40
LMNA P02545 3/20 0.39
TSHR P16473 3/20 0.39
HSD17B10 Q99714 1/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
PTPN1 P18031 1/20 0.34
PRKCA P17252 1/20 0.33
PRKCD Q05655 1/20 0.33
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
FDPS P14324 1/20 0.31
DNM1 Q05193 1/20 0.31
PSMD14 O00487 2/20 0.31
PLA2G1B P04054 2/20 0.31
MMP2 P08253 2/20 0.31
ATG4B Q9Y4P1 2/20 0.31
HSP90AA1 P07900 1/20 0.31
RAD52 P43351 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8402447 0.89 DNM1 (0.38) ALDH1A1SMN1; SMN2LMNATSHRPRKCA
SCHEMBL5805725 0.79 ALDH1A1 (0.36) ALDH1A1SMN1; SMN2TSHRPRKCAPRKCD
SCHEMBL5088890 0.78 DNM1 (0.31) DNM1
SCHEMBL17526883 0.77 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL17526575 0.77 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL11669709 0.77 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL7983818 0.76 ALDH1A1 (0.43) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL6538583 0.76 DNM1 (0.32) DNM1
SCHEMBL30977012 0.73 TSHR (0.46) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL8161093 0.73 SMN1; SMN2 (0.50) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1997046525-A1 5-ALKOXY-TRYPTAMINE DERIVATIVES, THEIR PREPARATION AND THEIR USE AS 5-HT1D RECEPTOR AGONISTS ALLELIX BIOPHARMACEUTICALS INC. (CA) 1997-12-11 WO disclosed